Automation Solution for Point-Of-Care (POC) Testing
Availability of rapid POC testing devices for detecting SARS-CoV-2, the virus that causes COVID-19, is what has saved lives. The faster a COVID-19 case can be confirmed, the sooner the affected person can receive medical care and begin isolation. Corona testing has played a significant part in Germany’s campaign to end the pandemic. Medical experts questioned why this country, one of the most affected by the pandemic, had such a low fatality rate. One explanation could be the widespread availability and use of rapid POC testing devices. This means that Germany had fewer unreported cases than many other countries, where testing was not as readily available. A direct consequence of more thorough testing of the population: Fewer patients died from the infection because more infected people with few or no symptoms were tested and isolated.
From Program Launch to Production Realization
At the start of the pandemic, the In Vitro Diagnostic [IVD] industry was not prepared to mass produce enough COVID-19 tests to meet demand. To increase capacity for production of these critical test devices, MA micro automation prioritized development of manufacturing systems configured to produce COVID-19 diagnostic test devices. This effort was prioritized to accommodate custom product designs while achieving rapid deployment of equipment to partner production sites.
|Reaction strip cutting station||Laser marking||3D laser scanner|